Skip to content

Clinical trials

Completed Brain Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Status: Completed Country / region: France Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20093
20111
20121
20163
20171
20182
20192
20203
20211
20226
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris6
AbbVie4
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
Slb Pharma2
Alkahest, Inc.1
BBB-Therapeutics B.V.1
Eli Lilly and Company1
Fondation Ophtalmologique Adolphe de Rothschild1
Groupe Hospitalier Pitie-Salpetriere1
Inmune Bio, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases26
Central Nervous System Diseases10
Nervous System Diseases10
Neurodegenerative Diseases7
Parkinson Disease6
Epilepsy4
Movement Disorders4
Parkinsonian Disorders4
Cerebral Palsy3
Dementia3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.